The stock slipped further to a low of Rs 390 - down 2.5% from the day's high. The stock finally ended flat at Rs 392. Around 97,333 shares changed hands at the counter today.
___________________________________________________
(Updated at 1837 hrs)
Pharma major, Ranbaxy, has added in trades this evening following a US court Ruling favouring the company.
The stock opened at the day's high of Rs 400 and slipped to a low of Rs 392. The stock is now trading with a marginal gain of Rs 3.60 or 1% at Rs 394. Around 43,414 shares have changed hands at the counter on the BSE so far.
The company has won a decisive ruling from New Jersey that its generic version of valganciclovir, prescribed for HIV/Aids patients and for organ transplantation-related infections, does not infringe the patent rights of Swiss drug maker Roche's anti-infection drug, Valcyte.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app